Xarelto, which is also known as rivaroxaban (its most active ingredient), is a popular anticoagulant drug that is usually taken orally, if possible. It is more commonly used by patients who had just undergone knee or hip replacement surgery, as a preventative measure against deep vein thrombosis (DVT). The US Food and Drug Administration (FDA) approved this drug back in 2011; its sales worldwide currently amount to around $1 billion.
There has, however, been significant evidence coming from numerous studies and complaints that have linked the consumption of Xarelto with possibly life threatening side effects such as gastrointestinal bleeding and brain hemorrhaging. Situations like this demand legal representation and recompense for the victims for the medical procedures required for recovery as well as lost wages and compensation for the trauma experienced after the event.
According to the website of Williams Kherkher, patients who had taken Xarelto in West Virginia have claimed that the manufacturers of the anticoagulant – Bayer and Janssen – had intentionally concealed knowledge of these side effects, despite knowing their consequences. This is supported by the information provided through a lawsuit filed in a federal court in Charleston when a woman filed a legal lawsuit against the drug, saying that taking Xarelto was the cause of her gastrointestinal bleeding and that the manufacturers were aware of the increased chances of this happening but offered no warning to its possible patients.
Several other sources have claimed that there are no treatments against the side effects of Xarelto, in contrast to other anticoagulants that have a protocol should side effects take place, and are continuously fighting for their right to receive due justice.Read More